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Nail fold capillaroscopy differs widely between
systemic sclerosis and chronic graft vs host
disease of the skin
SIR, Skin fibrosis is a common feature in patients with sclero-
derma (SSc) or chronic graft vs host disease (cGvHD) after
haemopoietic stem cell transplantation (HCST) with a rele-
vant impact on quality of life. Despite the similarities in
skin fibrosis, both diseases show several differences in
their clinical manifestation.
Nail fold capillaroscopy (NFC) is a simple and elegant
tool to study microvascular architecture non-invasively.
This well-established method is widely used in the diag-
nosis and follow-up of SSc patients [1]. In SSc, NFC
reveals a severe disarrangement of capillaries, giant capil-
laries, atypical forms, microhaemorrhages and capillary
rarefaction up to avascular fields differing quantitatively
in the time course and depending on disease activity
and therapy (Fig. 1). These morphological changes are
described as scleroderma pattern. Very often, but not ex-
clusively [2], this pattern is seen in patients with SSc. It
reflects the microvascular aetiology of the disease. The
role of vascular pathology in cGvHD is less well studied
and much more controversial [3, 4]. The involvement of
nail-fold capillaries by means of standard NFC has not yet
been investigated.
Here, we report on standard NFC findings in 11 patients
with sclerodermoid cGvHD. Six men and five women with
a median age of 43 years (range 2465 years) underwent
allogeneic HSCT from a related (6) or unrelated (5) donor
because of acute lymphoblastic (3) or acute myeloid (2) or
chronic myeloid leukaemia (2), lymphoma (3) or pure white
cell aplasia (1). All but one had received peripheral blood
stem cells. Median time since HSCT was 72 months
(range 28120 months), median time interval from diagno-
sis of cGvHD to NFC was 30 months (range 10118 months).
The severity of cGvHD according to the National Institutes
of Health scale [5] was severe in 10 and moderate in 1
patient. In cGvHD assessment of skin activity, the median
body surface areas affected by erythematous rash, teth-
ered and non-tethered sclerosis/fasciitis were 5% (range
010%), 5% (040%) and 15% (563%), respectively. All
but one patient were treated with calcineurin inhibitors or
sirolimus. Two were still under treatment with CSs, three
patients had imatinib, one nilotinib and one was treated
with rituximab 5 months before NFC. All patients had
stable disease at the time of examination. All patients under-
went NFC (Wild M8 binocular microscope, Heerbrugg,
Switzerland/JVC KY-F55B Videocamera, Japan) of fingers
IIV on both hands after they spent at least 10 min in a tem-
perate room (23C).
Nine patients showed excellent transparency of the
skin, whereas in two patients visualization of capillaries
was adequate. In general, a uniform pattern with a regular
appearance concerning number and arrangement of
capillaries was seen. Slightly tortuous capillaries were
seen in two and infrequent minor capillary haemorrhages
were seen in three individuals only. One patient showed
some isolated minimally enlarged capillaries. No giant
capillaries could be documented.
Our observation of a nearly normal capillaroscopic pat-
tern in patients with cGvHD is in contrast to the severe
capillary pathologies in 18 patients with sclerodermoid
cGvHD reported by Akay et al. [6]. There are several dif-
ferences between the patient characteristics described by
Akay et al. and our group, which may explain the different
findings. The most important difference is that RP—which
is an early and frequent clinical feature in SSc patients—
was present in 17% of Akay’s patients compared with
none in our series. Furthermore, none of their patients
was under immunosuppressive treatment at the time of
FIG. 1 (AC) Representative images of individuals with
cGvHD after HSCT. (A) A 51-year-old man 8 years after
HSCT because of chronic myeloid leukaemia. (B) A
23-year-old woman 3 years after HSCT because of
Hodgkin’s disease. (C) A 38year-old woman 7 years
post-HSCT due to acute myeloid leukaemia. All fingers
show a normal aspect with the exception of (C), featuring
sparse capillary bleeds (*). (D) A 31-year-old man 1 year
after the diagnosis of SSc, showing capillary bleeds, ca-
pillary thromboses, giant capillaries and avascular fields
as a typical sclerodermiform pattern, is shown for
comparison.
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NFC and median duration of cGvHD before NFC was
much shorter in their patient group (3 vs 30 months).
Fleming et al. [4] noted areas of microvascular prolifer-
ations in some cGvHD biopsies, especially in those with
a lichenoid histological picture. We do not know whether
the NFC abnormalities described by Akay et al. were dif-
ferent between patients with lichenoid changes (nine in
Akay’s report) or not, but we did not observe any NFC
abnormalities in our patients with lichenoid changes.
Furthermore, these authors used dermatoscopy—a
method that showed inferior reliability in patients with
SSc compared with standard NFC [7]. This fact may
have additionally contributed to the different interpretation
of the capillary morphology. On the other hand, our find-
ings support those of Fleming et al. [4] who could dem-
onstrate by histopathology only slight alterations in
superficial dermal microvessels in cGvHD in contrast to
patients with SSc, in whom capillaries were significantly
reduced in number, showed fewer canonical endothelial
markers and no microvascular endothelial proliferation.
In summary, our results further support the hypothesis
that cGvHD of the skin and SSc are two similar-looking
phenomena of skin fibrosis, but with a different patho-
physiology, and therefore may need different therapeutic
approaches. Thus, cGvHD patients and pathological find-
ings on NFC may represent a different group and should
be carefully evaluated for new-onset collagenosis.
Rheumatology key message
. Patients with cGvHD of the skin after HCST present
normal nail-fold capillary findings.
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Need for a consensus on the methods by which to
measure joint mobility and the definition of norms
for hypermobility that reflect age, gender and
ethnic-dependent variation: is revision of criteria for
joint hypermobility syndrome and EhlersDanlos
syndrome hypermobility type indicated?
SIR, Joint mobility is a continuous trait that varies with joint
location and is strongly influenced by age, gender and
ethnic origin. Variation in joint mobility probably begins
in utero and can be expressed, often most dramatically,
in individuals with heritable syndromes, such as forms of
EhlersDanlos syndrome (EDS) and various conditions in
which joint contracture is a conspicuous feature. In indi-
viduals with these disorders, the diagnosis generally de-
pends on the sum of the different features of the
condition, in a sense the gestalt of the presentation. In
general, the ability to formulate these diagnoses depends
in large part on the experience of the clinician and aware-
ness of the classical descriptions of the syndromes.
Individuals with syndromic forms of abnormalities in
joint mobility tend to fall into the diagnostic realm of the
geneticist, paediatrician, rheumatologist or other special-
ists, depending on the national preferences for referral.
Their clinical care is often assumed by rheumatologists
and physical therapists. A second and much larger
group of individuals occupies the attention of both
rheumatologists and geneticists—those who have joint
mobility that seems out of the usual range (usually
increased) at some point in their lives. They may have
acute or chronic subluxation, may have joint-related pain
that seems out of proportion to clinical signs and more
often than not are female. In part, because of the
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